Showing 1 - 9 results of 9 for search 'Sharon Nofech Mozes', query time: 0.03s Refine Results
  1. 1
    <i>MLH1</i> Methylation Testing as an Integral Component of Universal Endometrial Cancer Screening—A Critical Appraisal

    <i>MLH1</i> Methylation Testing as an Integral Component of Universal Endometrial Cancer Screening—A Critical Appraisal by Anna Plotkin, Ekaterina Olkhov-Mitsel, Sharon Nofech-Mozes

    Published 2023-10-01
    Get full text
    Article
  2. 2
    A Cluster-then-label Semi-supervised Learning Approach for Pathology Image Classification

    A Cluster-then-label Semi-supervised Learning Approach for Pathology Image Classification by Mohammad Peikari, Sherine Salama, Sharon Nofech-Mozes, Anne L. Martel

    Published 2018-05-01
    Get full text
    Article
  3. 3
    Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2+:ERα- breast cancer.

    Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2+:ERα- breast cancer. by Jeffrey C Liu, Miriam Zacksenhouse, Andrea Eisen, Sharon Nofech-Mozes, Eldad Zacksenhaus

    Published 2017-01-01
    Get full text
    Article
  4. 4
    Androgen Receptor Is Expressed in the Majority of Breast Cancer Brain Metastases and Is Subtype-Dependent

    Androgen Receptor Is Expressed in the Majority of Breast Cancer Brain Metastases and Is Subtype-Dependent by Kevin Yijun Fan, Rania Chehade, Maleeha Qazi, Veronika Moravan, Sharon Nofech-Mozes, Katarzyna J. Jerzak

    Published 2023-05-01
    Get full text
    Article
  5. 5
    Overcoming the limitations of patch-based learning to detect cancer in whole slide images

    Overcoming the limitations of patch-based learning to detect cancer in whole slide images by Ozan Ciga, Tony Xu, Sharon Nofech-Mozes, Shawna Noy, Fang-I Lu, Anne L. Martel

    Published 2021-04-01
    Get full text
    Article
  6. 6
    Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS?

    Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS? by Ezra Hahn, Danielle Rodin, Rinku Sutradhar, Sharon Nofech-Mozes, Sabina Trebinjac, Lawrence Frank Paszat, Eileen Rakovitch

    Published 2023-06-01
    Get full text
    Article
  7. 7
    Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force

    Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force by Hala Faragalla, Anna Plotkin, Penny Barnes, Fang-I Lu, Zuzana Kos, Anna Marie Mulligan, Anita Bane, Sharon Nofech Mozes

    Published 2023-03-01
    Get full text
    Article
  8. 8
    Biological Markers Predictive of Invasive Recurrence in DCIS

    Biological Markers Predictive of Invasive Recurrence in DCIS by Sharon Nofech-Mozes, Jacqueline Spayne, Eileen Rakovitch, Harriette J Kahn, Arun Seth, Jean-Phillippe Pignol, Lavina Lickley, Lawrence Paszat, Wedad Hanna M.D. FRCPC

    Published 2008-01-01
    Get full text
    Article
  9. 9
    High Expression of RECQL Protein in ER-Positive Breast Tumours Is Associated With a Better Survival

    High Expression of RECQL Protein in ER-Positive Breast Tumours Is Associated With a Better Survival by Ardalan Mahmoodi, Ardalan Mahmoodi, Ahmed Shoqafi, Ping Sun, Vasily Giannakeas, Vasily Giannakeas, Cezary Cybulski, Sharon Nofech-Mozes, Jean-Yves Masson, Sudha Sharma, Sudha Sharma, Amir Abbas Samani, Amir Abbas Samani, Srinivasan Madhusudan, Steven A. Narod, Steven A. Narod, Steven A. Narod, Mohammad R. Akbari, Mohammad R. Akbari, Mohammad R. Akbari

    Published 2022-05-01
    Get full text
    Article

Search Tools: